Effect of Genetic Variations on Rifamycins | PGPM - Dove Medical Press

Contributions of genetic variations in drug-metabolizing enzymes and transporter proteins to the inter-individual variation of rifamycins pharmacokinetics.

Introduction Tuberculosis (TB) is an infectious disease, which remains a major public health problem globally. In the year 2020, the estimated number of people who died from tuberculosis is 1.3 mill… [+38701 chars]

full article...